Monday, 26 October 2015

Research lab seeks volunteers in ‘Ebola’ medical trial: volunteers to be paid £750

Ebola virus

Hammersmith Medical Research is holding clinical trials to try and discover a vaccine to prevent more people dying from the Ebola virus in West Africa. The research lab is calling for volunteers willing to be injected with Ebola in a bid to find a cure for the disease.
Previous trials held by Oxford University in September involved patients being injected with a single protein from the Ebola virus to trigger an immune response. The organisers of the London trial, which will begin in November, are looking for healthy volunteers between the ages of 18 and 65 to take part in a similar experiment.
In an advert in the Evening Standard, the organisation wrote: "Interested in helping medical research into a vaccine for Ebola and being paid for your help?
"The current outbreak of Ebola in West Africa is estimated to have caused more than 10,000 deaths, and is still ongoing.
"There is no specific treatment or cure for Ebola.
"We hope that the study vaccine will prevent people becoming infected with Ebola."
The study involves up to 12 outpatient visits and could take place over the course of a year.
Since February 2014, almost 28,000 people across Sierra Leone, Guinea and Liberia have been struck down by Ebola, and more than 11,000 died. The Ebola virus is among the most lethal diseases known to man. There is no tested vaccine, no cure, and it kills 90% of infected patients.
Outbreaks typically occur in remote villages in Central and West Africa, near tropical rainforests. The spread of the disease is worsened by mistrust of western medicine in some African communities. Earlier this month Pauline Cafferkey , who had battled Ebola in January was left fighting for her life after a relapse of the disease.
But the leaders of the Hammersmith Medicines Research would like to reassure those interested in taking part in the trial there is no risk of catching Ebola by taking part in the study.
What if something goes wrong???

1 comment:

  1. the risks should be clearly stated though

    ReplyDelete